Vitex Pharmaceuticals

vitexpharma.com

Vitex Pharmaceuticals is a global leader in the contract manufacture of complementary medicine. From our state-of-the-art 26,000sqm best-in-class facility in Sydney, Australia, we are fully equipped to formulate, manufacture and package a wide variety of vitamins, minerals, herbal and nutritional supplements including tablets, softgel capsules, two-piece hardgel capsules and powders.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ALLIED EXPANDS PHARMACEUTICAL PIPELINE BY FILING US PROVISIONAL PATENT FOR PSILOCYBIN BASED THERAPEUTICS

Allied Corp | October 21, 2020

news image

Allied Corp, an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues is pleased to announce the filing of a new United States provisional patent application entitled “PSILOCYBIN COMPOSITIONS AND FORMULATIONS AND THEIR USE IN TREATING MENTAL HEALTH DISORDERS AND IMPROVING MENTAL HEALTH”. The provisional patent application covers a novel combination of psilocybin and proprietary mushroom f...

Read More

PHARMA TECH

INNOVATION ZED ANNOUNCE 2022 LAUNCH OF INSULCHECK DOSE ADD-ON TECHNOLOGY FOR INSULIN PENS

Zed | November 15, 2021

news image

Innovation Zed, developer of novel diabetes management technologies headquartered at NovaUCD, at University College Dublin, Ireland are delighted to announce today the arrival of the much anticipated InsulCheck DOSE technology that will be coming to market in 2022. "It is with great excitement that we announce the arrival of our InsulCheck DOSE by Innovation Zed. As the third generation product of the InsulCheck family, this technology has been a dream o...

Read More

PHARMACY MARKET

XERIS PHARMACEUTICALS COMPLETES ENROLLMENT OF ITS PHASE 1 STUDY OF LEVOTHYROXINE (XP-8121)

Xeris Pharmaceuticals, Inc. | September 01, 2021

news image

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that the company has completed enrollment and successfully dosed all participants in a Phase 1 study of levothyroxine (XP-8121) to evaluate the pharmacokinetics, safety and tolerability, and potential for weekly dosing of the investigational, novel, subcutaneous (SC) injection for the treatmen...

Read More

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

news image

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

Read More
news image

ALLIED EXPANDS PHARMACEUTICAL PIPELINE BY FILING US PROVISIONAL PATENT FOR PSILOCYBIN BASED THERAPEUTICS

Allied Corp | October 21, 2020

Allied Corp, an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues is pleased to announce the filing of a new United States provisional patent application entitled “PSILOCYBIN COMPOSITIONS AND FORMULATIONS AND THEIR USE IN TREATING MENTAL HEALTH DISORDERS AND IMPROVING MENTAL HEALTH”. The provisional patent application covers a novel combination of psilocybin and proprietary mushroom f...

Read More
news image

PHARMA TECH

INNOVATION ZED ANNOUNCE 2022 LAUNCH OF INSULCHECK DOSE ADD-ON TECHNOLOGY FOR INSULIN PENS

Zed | November 15, 2021

Innovation Zed, developer of novel diabetes management technologies headquartered at NovaUCD, at University College Dublin, Ireland are delighted to announce today the arrival of the much anticipated InsulCheck DOSE technology that will be coming to market in 2022. "It is with great excitement that we announce the arrival of our InsulCheck DOSE by Innovation Zed. As the third generation product of the InsulCheck family, this technology has been a dream o...

Read More
news image

PHARMACY MARKET

XERIS PHARMACEUTICALS COMPLETES ENROLLMENT OF ITS PHASE 1 STUDY OF LEVOTHYROXINE (XP-8121)

Xeris Pharmaceuticals, Inc. | September 01, 2021

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that the company has completed enrollment and successfully dosed all participants in a Phase 1 study of levothyroxine (XP-8121) to evaluate the pharmacokinetics, safety and tolerability, and potential for weekly dosing of the investigational, novel, subcutaneous (SC) injection for the treatmen...

Read More
news image

PHARMA TECH

PRESCRYPTIVE HEALTH LAUNCHES COMPREHENSIVE PHARMACY MANAGEMENT PLATFORM TO EXPAND THE SCOPE OF COMMUNITY PHARMACISTS

Prescryptive Health | October 06, 2021

Healthcare technology company Prescryptive Health today announced that MyRx PRO is now operational nationwide. The pharmacy management platform allows pharmacists to digitize their business with new revenue opportunities through profitable clinical services and a deeper patient engagement experience. Today we change the course of the community pharmacist, by empowering them to expand their business and meet new customers through new services, all on our secure platfo...

Read More